About 60–65% of commercial insurance plans covered Zepbound (tirzepatide) for weight loss as of mid-2026. Getting covered almost always requires prior authorization, and about 41% of first requests are denied — but most denials are overturned on appeal with the right documentation. This guide walks through who qualifies, which insurers cover tirzepatide, how to get prior authorization approved, what to do if you are denied, and the best self-pay alternatives when insurance doesn’t work.
Key takeaways
- About 60–65% of major commercial plans cover Zepbound in 2026, almost always with prior authorization.
- Medicare Part D cannot cover Zepbound for weight loss by federal law — but can cover Mounjaro for type 2 diabetes.
- The OSA pathway: Zepbound is also FDA-approved for obstructive sleep apnea — some plans cover it for OSA even when they exclude it for weight loss.
- ~41% of first PA requests are denied. Most are overturned on appeal with proper documentation.
- You need BMI ≥30, or BMI ≥27 plus a qualifying comorbidity, to meet the medical criteria most plans require.
- Step therapy is common — some plans require trying a cheaper weight loss drug first.
- If insurance fails, LillyDirect self-pay vials cost $299–$449/month with no insurance needed.
- The Lilly Savings Card cuts costs to as low as $25/month for eligible patients with commercial coverage.
Does insurance cover tirzepatide?
The short answer: often yes, but never automatically. Tirzepatide comes in two FDA-approved brands with different coverage rules:
- Zepbound — FDA-approved for chronic weight management (November 2023) and obstructive sleep apnea (June 2024). Requires prior authorization at most plans. Excluded from Medicare for weight loss.
- Mounjaro — FDA-approved for type 2 diabetes (May 2022). Covered by Medicare Part D and most commercial plans for diabetes. Broader coverage than Zepbound because diabetes is a more covered indication.
Both contain the same active drug — tirzepatide, a dual GLP-1 and GIP receptor agonist made by Eli Lilly. The coverage difference is about the FDA-approved indication, not the medication itself.
Tirzepatide cost with and without insurance in 2026
| How you pay | Monthly cost | Notes |
|---|---|---|
| Commercial insurance (approved) + savings card | As low as $25 | Requires PA approval and formulary coverage |
| Commercial insurance (approved, no card) | $40–$250 | Depends on tier and deductible |
| LillyDirect self-pay vials | $299–$449 | No insurance needed; vials only |
| No insurance, retail pharmacy | ~$1,086 | List price; rare to pay this |
| Medicare Part D | Not covered for weight loss | Covered for T2D (Mounjaro) or OSA |
The old list price figures ($1,059.97 for Zepbound) have been replaced by the current $1,086 retail cost. LillyDirect prices dropped to $299–$449 in December 2025 — making self-pay much more accessible than when this article was originally written.
Which insurance plans cover Zepbound?
Coverage depends on your specific plan, not just the insurer name. Two people on the same insurance company can have completely different formularies. That said, here is how major insurers break down in 2026:
| Insurer | Zepbound coverage | Typical copay (approved) |
|---|---|---|
| UnitedHealthcare | Most group plans cover it with PA | $25–$100/month |
| Aetna | Group plans often cover it; some 2026 plans dropped it | $40–$250/month |
| Cigna | Most commercial plans with PA | $25–$150/month |
| Blue Cross Blue Shield | Varies by state/plan; some plans restricted in 2026 | $25–$200/month |
| Humana | Commercial plans with PA | Varies |
| Kaiser Permanente | Covered with PA on most plans | Varies |
| Medicare Part D | Not covered for weight loss; covered for T2D via Mounjaro | N/A for Zepbound |
| Medicaid | Varies by state; 18 states cover for obesity | Varies |
Key 2026 change: Aetna dropped Zepbound from some formularies in 2026. Some BCBS plans also restricted coverage for weight-loss-only indications. Always check your current year’s formulary — don’t assume last year’s coverage still applies.
Who qualifies for insurance coverage of tirzepatide?
Most insurance plans follow FDA-approved prescribing criteria. To qualify, you generally need:
- BMI of 30 or higher (obesity), or
- BMI of 27 or higher with at least one weight-related condition:
- Type 2 diabetes
- Hypertension (high blood pressure)
- Dyslipidemia (high cholesterol)
- Obstructive sleep apnea
- Cardiovascular disease
Your prescribing provider documents these criteria in the prior authorization request. Without the documentation, the PA will almost certainly fail.
The OSA pathway. Zepbound is also FDA-approved for moderate-to-severe obstructive sleep apnea in adults with obesity. Some plans cover Zepbound for OSA even when they exclude it for weight loss. If you have diagnosed sleep apnea, ask your provider to include this in the PA request — it may open a coverage path that the weight-loss indication alone would not.
How to get tirzepatide covered by insurance: step by step
Step 1: Check your plan’s formulary
Log into your insurance portal or call member services. Search for “tirzepatide,” “Zepbound,” or “Mounjaro.” The formulary will show:
- Whether the drug is covered
- Which tier it sits on (higher tier = higher copay)
- Whether prior authorization is required
- Any quantity limits or step therapy requirements
If Zepbound is not on your formulary, check whether Mounjaro is — if you have type 2 diabetes, Mounjaro coverage may be easier to obtain.
Step 2: Get a prescription from a licensed provider
You need a valid prescription from a licensed provider before a prior authorization can be submitted. Heally connects patients with board-certified physicians through telehealth — same-day appointments, prescription delivered to your door.
Book a free consultation with Heally to start the process.
Step 3: Submit a prior authorization request
Your provider submits the PA on your behalf. A complete PA package typically includes:
- Your BMI documented in the medical record
- Documentation of qualifying comorbidities (hypertension, diabetes, OSA, etc.)
- Evidence of prior lifestyle intervention (diet and exercise attempts)
- Medical necessity statement from your provider
- FDA prescribing criteria checklist
PA processing typically takes 3 to 14 business days. About 41% of first requests are denied. Don’t stop here if you get a denial.
Step 4: Satisfy step therapy requirements (if required)
Some plans require you to try and fail on an older, cheaper weight loss medication first before approving tirzepatide. This is called step therapy. Common step therapy requirements:
- Trying a lower-cost medication such as phentermine, topiramate, or bupropion/naltrexone (Contrave)
- Completing a structured weight management program
- Documenting a minimum period on the step drug with insufficient results
Ask your provider to document any previous weight loss attempts in your chart. Past participation in a program, previous prescriptions, or documented failed approaches all count.
Step 5: If denied, appeal
A denial is not final. In 2022, the American Medical Association found that 83.2% of appealed prior authorization denials resulted in a full or partial overturn. The process:
- Request the denial in writing with the specific reason code.
- Ask your provider to write a letter of medical necessity that directly addresses the denial reason.
- Include your BMI records, comorbidity documentation, and any supporting clinical literature.
- Submit the appeal within your plan’s window (usually 30–60 days from denial).
If internal appeal fails, ask for an external independent review. You are entitled to one under the ACA.
Can’t wait for PA approval? If you need to start treatment now while your insurance works out, LillyDirect self-pay vials start at $299/month with no insurance required. Get a prescription from Heally and order through LillyDirect the same week.
Medicare and Medicaid coverage of tirzepatide
Medicare
Medicare Part D cannot cover Zepbound for weight loss under current federal law. This is a statutory exclusion — not a formulary decision. Zepbound’s NDC (drug code) is flagged at the system level and automatically rejected regardless of diagnosis code.
What Medicare can cover:
- Mounjaro for type 2 diabetes — covered under Part D since Mounjaro has a diabetes indication.
- Zepbound for obstructive sleep apnea — the coverage landscape here is still developing in 2026.
Medicare patients who want tirzepatide for weight loss have two practical paths:
- Use LillyDirect self-pay vials ($299–$449/month cash, out of pocket).
- Talk to their provider about whether Mounjaro under a type 2 diabetes diagnosis is appropriate.
Medicaid
Coverage varies dramatically by state:
- 18 states cover GLP-1 medications for obesity without requiring a diabetes diagnosis.
- 32 states cover GLP-1s only for diabetes (meaning Mounjaro coverage, not Zepbound for weight loss).
- Some state Medicaid programs (such as California’s Medi-Cal) cover Zepbound with no prior authorization required.
Check your state Medicaid formulary directly, or ask your provider to check on your behalf.
What if insurance doesn’t cover tirzepatide?
If your plan doesn’t cover tirzepatide or your appeal fails, you still have three solid options.
Option 1: LillyDirect self-pay vials
Eli Lilly’s direct pharmacy program sells single-dose tirzepatide vials at cash prices that bypass insurance entirely. No insurance needed — just a valid prescription.
| Dose | Monthly price |
|---|---|
| 2.5 mg (starter) | $299 |
| 5 mg | $399 |
| 7.5–15 mg | $449 (with 45-day refill) |
These prices are the same whether you have insurance or not. Vials can be picked up at Walmart or delivered to your home. See our full Zepbound cost guide for the complete pricing breakdown.
Option 2: Lilly Savings Card
If your commercial insurance covers tirzepatide but your copay is still high, the Lilly Savings Card can reduce your cost to as low as $25/month. See our Zepbound savings card guide for enrollment steps.
Not available for Medicare, Medicaid, TRICARE, or VA beneficiaries.
Option 3: Consider semaglutide
If tirzepatide isn’t covered but weight loss treatment is a priority, semaglutide products (Wegovy or Ozempic) may have better coverage on your specific plan. Wegovy covers similar BMI criteria and has FDA approval going back to 2021, giving it more formulary time. Wegovy also offers a $149/month self-pay option through the Wegovy pill.
See our comparison of tirzepatide vs semaglutide to understand which fits better for your situation.
Conclusion
Getting tirzepatide covered by insurance in 2026 takes preparation, but it’s achievable for most people with commercial coverage. The steps are: verify your formulary, get a prescription with full comorbidity documentation, submit a thorough PA, and appeal any denial. Most appeals succeed.
If insurance isn’t an option — Medicare, Medicaid in a non-covered state, or a self-funded employer plan that excludes weight-loss drugs — LillyDirect self-pay at $299–$449/month is the next best legitimate path.
Book a free consultation with Heally to get a tirzepatide prescription with complete prior authorization support — same-day appointments available in 40+ states.
FAQ
Does insurance cover Zepbound in 2026?
About 60–65% of major commercial insurance plans cover Zepbound with prior authorization. Coverage varies by plan and employer. Medicare Part D cannot cover Zepbound for weight loss by federal law.
What BMI do I need for insurance to cover tirzepatide?
Most plans require a BMI of 30 or higher, or a BMI of 27 or higher with at least one qualifying condition such as hypertension, type 2 diabetes, dyslipidemia, or obstructive sleep apnea. Document these conditions thoroughly in your PA request.
How long does prior authorization for Zepbound take?
Most prior authorization decisions take 3 to 14 business days from a complete submission. Urgent requests can sometimes be processed faster. Ask your provider to flag the request as urgent if medically necessary.
What happens if my Zepbound prior authorization is denied?
Request the denial in writing, then appeal with a letter of medical necessity from your provider addressing the specific denial reason. The AMA found 83.2% of prior authorization appeals were fully or partially overturned in 2022. You also have the right to request an external independent review.
Does Medicare cover tirzepatide?
Medicare Part D cannot cover Zepbound for weight loss by law. Medicare can cover Mounjaro for type 2 diabetes. Medicare Advantage plans may offer limited supplemental coverage for obesity drugs, but fewer than 5% do. Medicare patients can use LillyDirect self-pay ($299–$449/month) or talk to their provider about Mounjaro under a T2D indication.
Is tirzepatide cheaper with insurance or through LillyDirect?
It depends. With commercial insurance and the Lilly Savings Card, you may pay as little as $25/month. Without coverage, LillyDirect vials at $299–$449/month are often cheaper than using the savings card alone on an uncovered plan ($499+ for pens).
What is step therapy for Zepbound?
Step therapy means your insurer requires you to try and fail on a cheaper medication first before approving Zepbound. Common step drugs include phentermine, Contrave (bupropion/naltrexone), or Qsymia. Document any past attempts in your medical record — prior use often satisfies this requirement.
Can a telehealth provider help with prior authorization?
Yes. Heally’s licensed physicians can prescribe tirzepatide and assist with prior authorization documentation. They can document your BMI, comorbidities, and medical necessity to support a complete PA submission.
Related reading on Heally:
- How much does Zepbound cost in 2026? A complete pricing guide
- How to use the Zepbound savings card: a complete 2026 discount guide
- Tirzepatide vs semaglutide: key differences and weight loss results
- What to expect during your first three months on Zepbound
Sources
- Eli Lilly — Zepbound coverage and savings for patients
- Eli Lilly — LillyDirect self-pay pricing for Zepbound vials
- FDA — Zepbound (tirzepatide) prescribing information, 2024
- AMA — Over 80% of prior auth appeals succeed
- HHS — The Affordable Care Act and obesity coverage requirements
- Drugs.com — Is Zepbound covered by insurance?
- NEJM — Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1)
Medical disclaimer: This article is for informational purposes only. Insurance coverage, pricing, and eligibility criteria change frequently. Always verify coverage with your insurance provider before starting treatment. Consult a licensed healthcare provider before starting, stopping, or changing any prescription medication. Individual results vary.
